Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Icosapent Ethyl on Ventricular Remodeling, Inflammation, and Coronary Plaque Stability in Patients With Acute or Chronic Coronary Syndrome: A Prospective, Observational, Real-World Study

NCT07641257 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT07641257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07641257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Icosapent Ethyl on Ventricular Remodeling, Inflammation, and Coronary Plaque Stability in Patients With Acute or Chronic Coronary Syndrome: A Prospective, Observational, Real-World Study
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
May 30, 2026
Completion date
May 30, 2029
Enrollment
420 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes (acs), atherosclerosis cardiovascular disease, chronic coronary syndrome, coronary artery disease, inflammation, ventricular remodeling